The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Takeda
Pomalidomide, bortezomib, and dexamethasone (PVd) in lenalidomide (LEN)-pretreated relapsed refractory multiple myeloma: Subanalysis of patients with renal impairment in OPTIMISMM.
 
Fredrik Schjesvold
Stock and Other Ownership Interests - Nordic Nanovector; Oncopeptides
Honoraria - Amgen; Celgene; Janssen; Skyline Diagnostics; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Oncopeptides; Sanofi
Research Funding - Celgene; Janssen
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
 
Meral Beksac
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene
 
Jindriska Lindsay
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Takeda
(OPTIONAL) Uncompensated Relationships - Amgen; Bristol-Myers Squibb; Celgene; Takeda
 
Anna Marina Liberati
Consulting or Advisory Role - Incyte
Research Funding - Abbvie; Amgen; Archigen Biotech; BeiGene; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Takeda; Verastem
 
Monica Galli
No Relationships to Disclose
 
Pawel Robak
No Relationships to Disclose
 
Katja Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Research Funding - Celgene; Janssen
 
Alessandra Larocca
No Relationships to Disclose
 
Münci Yagci
No Relationships to Disclose
 
Filiz Vural
Leadership - Er-Kim Ilaç (Inst)
Honoraria - Amgen (Inst); BMS Turkey (Inst); Takeda (Inst)
Consulting or Advisory Role - Er-Kim Ilaç (Inst)
Speakers' Bureau - Celgene (Inst); Janssen (Inst)
Research Funding - Celgene (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Gen (Inst); Novartis (Inst); Takeda (Inst)
 
Larry D. Anderson, Jr
Honoraria - Amgen; celgene; GlaxoSmithKline; janssen; takeda
Consulting or Advisory Role - amgen; Bristol-Myers Squibb; celgene; GlaxoSmithKline; janssen
Speakers' Bureau - amgen; celgene; Takeda
Research Funding - amgen; Bristol-Myers Squibb; celgene; janssen
 
Abraham Sebastian Kanate
Travel, Accommodations, Expenses - Array BioPharma
 
Eva Casal Mendez
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ruiyun Jiang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Shankar Srinivasan
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Lara Grote
No Relationships to Disclose
 
Tsvetan Nikolov Biyukov
No Relationships to Disclose
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)